3/17
08:04 am
ptix
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 [Yahoo! Finance]
Low
Report
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 [Yahoo! Finance]
12/30
04:14 pm
ptix
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.